TITLE:
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients

CONDITION:
Diarrhea

INTERVENTION:
Crofelemer

SUMMARY:

      To evaluate the efficacy, safety, and durability of response of SP-303 in decreasing stool
      weight in AIDS patients with diarrhea over 6 days of treatment.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  HIV infection meeting CDC criteria for AIDS.

          -  History of diarrhea for greater than or equal to 14 days prior to screening period
             (Day 1).

        Required:

        - On stable medical regimen.
      
